Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Adamts7 (a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7) Mus musculus
Analyze
Symbol: Adamts7
Name: a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7
Description: Exhibits metallopeptidase activity. Involved in proteolysis. Localizes to the cell surface. Is expressed in several structures, including bone; cartilage; embryo mesenchyme; and vibrissa. Orthologous to human ADAMTS7 (ADAM metallopeptidase with thrombospondin type 1 motif 7).
Type: protein-coding
RefSeq Status: REVIEWED
Also known as: A disintegrin and metalloproteinase with thrombospondin motifs 7; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 7; ADAM-TS 7; ADAM-TS7; ADAMTS-7; ADAMTS7B; COMPase; metalloprotease
Orthologs:
Latest Assembly: GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm38 Ensembl990,163,069 - 90,208,071 (+)Ensembl
GRCm38990,162,904 - 90,200,102 (+)NCBIGRCm38GRCm38mm10GRCm38
MGSCv37990,057,816 - 90,094,940 (+)NCBIGRCm37mm9NCBIm37
MGSCv36989,961,138 - 89,997,904 (+)NCBImm8
Celera989,777,163 - 89,814,434 (+)NCBICelera
Cytogenetic Map9 E3.1NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Phenotype Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (GRCm38)
miRNA Target Status

Expression


Sequence

Nucleotide Sequences
Protein Sequences
Promoters

Additional Information

External Database Links
 
More on Adamts7
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: mm9 mm10
MGI Report
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1315488
Created: 2005-01-12
Species: Mus musculus
Last Modified: 2019-11-27
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.